These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21723224)

  • 1. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: state of the science, future directions.
    Baker KS; Bhatia S; Bunin N; Nieder M; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Pulsipher MA
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1424-7. PubMed ID: 21723224
    [No Abstract]   [Full Text] [Related]  

  • 2. NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challenges.
    Bhatia S; Davies SM; Scott Baker K; Pulsipher MA; Hansen JA
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1428-35. PubMed ID: 21763253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomes.
    Parsons SK; Phipps S; Sung L; Baker KS; Pulsipher MA; Ness KK
    Biol Blood Marrow Transplant; 2012 Feb; 18(2):162-71. PubMed ID: 22155139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks.
    Dvorak CC; Gracia CR; Sanders JE; Cheng EY; Baker KS; Pulsipher MA; Petryk A
    Biol Blood Marrow Transplant; 2011 Dec; 17(12):1725-38. PubMed ID: 22005649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines.
    Pulsipher MA; Skinner R; McDonald GB; Hingorani S; Armenian SH; Cooke KR; Gracia C; Petryk A; Bhatia S; Bunin N; Nieder ML; Dvorak CC; Sung L; Sanders JE; Kurtzberg J; Baker KS
    Biol Blood Marrow Transplant; 2012 Mar; 18(3):334-47. PubMed ID: 22248713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Introduction to the reports from the National Cancer Institute First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation.
    Bishop MR; Alyea EP; Cairo MS; Falkenburg JH; June CH; Kröger N; Little RF; Miller JS; Pavletic SZ; Porter D; Riddell SR; van Besien K; Wayne AS; Weisdorf DJ; Wu R; Giralt S
    Biol Blood Marrow Transplant; 2010 May; 16(5):563-4. PubMed ID: 20202482
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-Term Morbidity and Mortality in Children with Chronic Graft-versus-Host Disease Classified by National Institutes of Health Consensus Criteria after Allogeneic Hematopoietic Stem Cell Transplantation.
    Inagaki J; Moritake H; Nishikawa T; Hyakuna N; Okada M; Suenobu S; Nagai K; Honda Y; Shimomura M; Fukano R; Noguchi M; Kurauchi K; Tanioka S; Okamura J
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1973-80. PubMed ID: 26234723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Acute Respiratory Distress Syndrome in Pediatric Allogeneic Hematopoietic Stem Cell Transplants: A Multicenter Study.
    Rowan CM; Smith LS; Loomis A; McArthur J; Gertz SJ; Fitzgerald JC; Nitu ME; Moser EA; Hsing DD; Duncan CN; Mahadeo KM; Moffet J; Hall MW; Pinos EL; Tamburro RF; Cheifetz IM;
    Pediatr Crit Care Med; 2017 Apr; 18(4):304-309. PubMed ID: 28178076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation.
    Shenoy S; Angelucci E; Arnold SD; Baker KS; Bhatia M; Bresters D; Dietz AC; De La Fuente J; Duncan C; Gaziev J; King AA; Pulsipher MA; Smith AR; Walters MC
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):552-561. PubMed ID: 28065838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Shenoy S; Gaziev J; Angelucci E; King A; Bhatia M; Smith A; Bresters D; Haight AE; Duncan CN; de la Fuente J; Dietz AC; Baker KS; Pulsipher MA; Walters MC
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1313-1321. PubMed ID: 29653206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early and late complications following hematopoietic stem cell transplantation in pediatric patients - A retrospective analysis over 11 years.
    Hierlmeier S; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2018; 13(10):e0204914. PubMed ID: 30325953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Institutes of Health-Defined Chronic Graft-vs.-Host Disease in Pediatric Hematopoietic Stem Cell Transplantation Patients Correlates With Parameters of Long-Term Immune Reconstitution.
    Lawitschka A; Gueclue ED; Januszko A; Körmöczi U; Rottal A; Fritsch G; Bauer D; Peters C; Greinix HT; Pickl WF; Kuzmina Z
    Front Immunol; 2019; 10():1879. PubMed ID: 31507582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation.
    Broglie L; Fretham C; Al-Seraihy A; George B; Kurtzberg J; Loren A; MacMillan M; Martinez C; Davies SM; Pasquini MC
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2024-2030. PubMed ID: 31201861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study.
    Doucette K; Tian X; Chawla U; Jain NA; Chen M; Ito S; Bogaty P; Koklanaris E; Barrett J; Battiwalla M
    Bone Marrow Transplant; 2019 Feb; 54(2):320-322. PubMed ID: 30104719
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features of late onset non-infectious pulmonary complications following pediatric allogeneic hematopoietic stem cell transplantation.
    Park M; Koh KN; Kim BE; Im HJ; Seo JJ
    Clin Transplant; 2011; 25(2):E168-76. PubMed ID: 21077955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National Cancer Institute's First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: summary and recommendations from the organizing committee.
    Bishop MR; Alyea EP; Cairo MS; Falkenburg JH; June CH; Kröger N; Little RF; Miller JS; Pavletic SZ; Porter DL; Riddell SR; van Besien K; Wayne AS; Weisdorf DJ; Wu RS; Giralt S
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):443-54. PubMed ID: 21224011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hematopoietic stem cell transplantation in unique pediatric populations: adolescents, infants, and children with down syndrome.
    Duncan CN; Clark JJ; Silverman LB
    Biol Blood Marrow Transplant; 2013 Jan; 19(1 Suppl):S52-7. PubMed ID: 23085602
    [No Abstract]   [Full Text] [Related]  

  • 18. NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.
    Miller JS; Warren EH; van den Brink MR; Ritz J; Shlomchik WD; Murphy WJ; Barrett AJ; Kolb HJ; Giralt S; Bishop MR; Blazar BR; Falkenburg JH
    Biol Blood Marrow Transplant; 2010 May; 16(5):565-86. PubMed ID: 20152921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
    Griffith LM; Pavletic SZ; Tyndall A; Bredeson CN; Bowen JD; Childs RW; Gratwohl A; van Laar JM; Mayes MD; Martin R; McSweeney PA; Muraro PA; Openshaw H; Saccardi R; Sandmaier BM; Forman SJ; Nash RA;
    Biol Blood Marrow Transplant; 2005 Nov; 11(11):862-70. PubMed ID: 16275589
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogenic hematopoietic stem cell transplantation in sickle cell disease.
    Furstenau DK; Tisdale JF
    Transfus Apher Sci; 2021 Feb; 60(1):103057. PubMed ID: 33485798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.